AMY SIRKIN: Open Payments
NPI 1972528479 · SOMERSET, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$181 in 11 payments from 8 companies in 2025. Trend: 2023 $928 · 2024 $605 · 2025 $181
Food & beverage: $181
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $36 |
| Lilly USA, LLC | 2 | $36 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| Amgen Inc. | 1 | $15 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $13 |
Products named: UBRELVY, SHINGRIX, JARDIANCE, CAPVAXIVE, MOUNJARO, OTEZLA, FARXIGA, VOQUEZNA.
Industry payments across NJ — which companies pay providers there.
